H.R. 5819: Balancing Incentives Act of 2025
The Balancing Incentives Act of 2025 proposes to amend U.S. patent law, specifically Title 35 of the United States Code. The main focus of this bill is to change the requirements for filing certain types of petitions related to patents, called inter partes review and post-grant review.
Key Changes Proposed
Under the new provisions, a key requirement will be introduced: the owner of a patent must provide consent for anyone to file a petition for an inter partes review or a post-grant review. This means that:
- Individuals or entities who wish to challenge the validity of a patent through these specific review processes will have to obtain permission from the patent owner before doing so.
- This change aims to give patent owners more control over the patent review process, potentially making it more difficult for challengers to initiate reviews without the owner's consent.
Impact of the Changes
The proposed amendments could have several implications:
- Patents may be more secure as owners will have the ability to block challenges unless they agree to them.
- It could reduce the number of inter partes and post-grant reviews initiated, as challengers would need to negotiate with patent holders for consent.
- This may impact innovation and competition in industries where patents play a crucial role, although the exact effects would depend on how the new rule alters the behavior of patent holders and potential challengers.
Considerations
By requiring consent, the bill aims to balance the interests of patent owners against those who wish to contest patents. There could be debates on whether this change will promote or stifle innovation and competition within patent-heavy industries.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
4 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Oct. 24, 2025 | Introduced in House |
| Oct. 24, 2025 | Referred to the House Committee on the Judiciary. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.